• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于树状高分子的纳米结构在糖尿病管理中的应用:综述。

Dendrimer Based Nanoarchitectures in Diabetes Management: An Overview.

机构信息

School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.

School of Pharmacy and Technology Management, SVKM's NMIMS, Shirpur, India.

出版信息

Curr Pharm Des. 2019;25(23):2569-2583. doi: 10.2174/1381612825666190716125332.

DOI:10.2174/1381612825666190716125332
PMID:31333099
Abstract

Diabetes has turned out to be one of the biggest worldwide health and economic burdens, with its expanded predominance and high complexity proportion. The quantity of diabetic patients is expanding enormously around the world. Several reports have demonstrated the sharp increment in the sufferers. Stable and acceptable blood glucose control is fundamental to diminish diabetes-related complications. Consequently, ceaseless endeavors have been made in antidiabetic drugs, treatment strategies, and nanotechnology based products to accomplish better diabetes control. The nanocarriers pertaining hypoglycaemics provide improved diabetes management with minimum risk of associated side effects. Dendrimers have caught an incredible attention in the field of drug delivery and personalized medicines. Dendrimers are three-dimensional well-defined homogenous nanosized structures consisting tree-like branches. The present review highlights the different aspects of dendrimers including fabrication, surface engineering, toxicological profile as well as delivery of antidiabetic drugs for the effective cure of diabetes.

摘要

糖尿病已成为全球最大的健康和经济负担之一,其发病率不断上升且复杂程度高。全球范围内糖尿病患者数量正在大幅增加。有几项报告表明患者数量急剧增加。稳定和可接受的血糖控制对于减少糖尿病相关并发症至关重要。因此,人们一直在努力开发抗糖尿病药物、治疗策略和基于纳米技术的产品,以实现更好的糖尿病控制。低血糖纳米载体提供了改善的糖尿病管理,同时最小化了相关副作用的风险。树状聚合物在药物输送和个性化药物领域引起了广泛关注。树状聚合物是一种具有三维结构、明确的、均一的纳米级结构,由树枝状分支组成。本综述重点介绍了树状聚合物的不同方面,包括其制备、表面工程、毒理学特性以及抗糖尿病药物的传递,以有效治疗糖尿病。

相似文献

1
Dendrimer Based Nanoarchitectures in Diabetes Management: An Overview.基于树状高分子的纳米结构在糖尿病管理中的应用:综述。
Curr Pharm Des. 2019;25(23):2569-2583. doi: 10.2174/1381612825666190716125332.
2
Dendrimer-based nanocarriers: a versatile platform for drug delivery.基于树枝状大分子的纳米载体:一种用于药物递送的多功能平台。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jan;9(1). doi: 10.1002/wnan.1409. Epub 2016 Apr 29.
3
Nanotechnology based approaches for anti-diabetic drugs delivery.基于纳米技术的抗糖尿病药物传递方法。
Diabetes Res Clin Pract. 2018 Feb;136:52-77. doi: 10.1016/j.diabres.2017.11.018. Epub 2017 Nov 28.
4
Nanotechnology Advanced Strategies for the Management of Diabetes Mellitus.纳米技术在糖尿病管理中的先进策略。
Curr Drug Targets. 2019;20(10):995-1007. doi: 10.2174/1389450120666190307101642.
5
Therapeutic medications against diabetes: What we have and what we expect.治疗糖尿病的药物:我们有什么和我们期望什么。
Adv Drug Deliv Rev. 2019 Jan 15;139:3-15. doi: 10.1016/j.addr.2018.11.008. Epub 2018 Dec 5.
6
Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery.树枝状大分子的药物应用:用于药物递送的有前景的纳米载体。
Front Biosci. 2008 Jan 1;13:1447-71. doi: 10.2741/2774.
7
Nanomaterials for diabetes: diagnosis, detection and delivery.用于糖尿病的纳米材料:诊断、检测与递送。
Nanotechnology. 2024 Jul 11;35(39). doi: 10.1088/1361-6528/ad5db5.
8
Dendrimers: A versatile nanocarrier for drug delivery and targeting.树状高分子:一种用于药物传递和靶向的多功能纳米载体。
Int J Pharm. 2018 Sep 5;548(1):707-720. doi: 10.1016/j.ijpharm.2018.07.030. Epub 2018 Jul 21.
9
Recent progress in dendrimer-based nanocarriers.基于树枝状大分子的纳米载体的最新进展。
Crit Rev Ther Drug Carrier Syst. 2006;23(6):437-95. doi: 10.1615/critrevtherdrugcarriersyst.v23.i6.10.
10
Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery.用于癌症诊断和抗癌药物递送的树枝状大分子纳米结构。
Drug Discov Today. 2017 Feb;22(2):314-326. doi: 10.1016/j.drudis.2016.09.013. Epub 2016 Sep 23.

引用本文的文献

1
Nanotechnology-based drug delivery system for the diagnosis and treatment of ovarian cancer.用于卵巢癌诊断与治疗的基于纳米技术的药物递送系统。
Discov Oncol. 2025 Mar 29;16(1):422. doi: 10.1007/s12672-025-02062-9.
2
Channel Expansion in the Ligand-Binding Domain of the Glucocorticoid Receptor Contributes to the Activity of Highly Potent Glucocorticoid Analogues.配体结合域中的糖皮质激素受体通道扩张有助于高效糖皮质激素类似物的活性。
Molecules. 2024 Mar 29;29(7):1546. doi: 10.3390/molecules29071546.
3
Cationic Materials for Gene Therapy: A Look Back to the Birth and Development of 2,2-Bis-(hydroxymethyl)Propanoic Acid-Based Dendrimer Scaffolds.
阳离子材料在基因治疗中的应用:回溯基于 2,2-双羟甲基丙酸的树枝状大分子支架的诞生和发展。
Int J Mol Sci. 2023 Nov 6;24(21):16006. doi: 10.3390/ijms242116006.
4
Three-Dimensional In Vitro Tumor Spheroid Models for Evaluation of Anticancer Therapy: Recent Updates.用于评估抗癌治疗的三维体外肿瘤球体模型:最新进展
Cancers (Basel). 2023 Oct 4;15(19):4846. doi: 10.3390/cancers15194846.
5
Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.纳米技术在卵巢癌诊断和治疗中的应用:近期趋势综述。
Drug Deliv. 2022 Dec;29(1):3218-3232. doi: 10.1080/10717544.2022.2132032.
6
Dendrimers, an Emerging Opportunity in Personalized Medicine?树枝状大分子,个性化医疗的新机遇?
J Pers Med. 2022 Aug 19;12(8):1334. doi: 10.3390/jpm12081334.
7
Delivery of therapeutic agents and cells to pancreatic islets: Towards a new era in the treatment of diabetes.治疗剂和细胞向胰岛的递送:糖尿病治疗的新时代。
Mol Aspects Med. 2022 Feb;83:101063. doi: 10.1016/j.mam.2021.101063. Epub 2021 Dec 24.
8
Emerging Treatment Strategies for Diabetes Mellitus and Associated Complications: An Update.糖尿病及其相关并发症的新兴治疗策略:最新进展
Pharmaceutics. 2021 Sep 27;13(10):1568. doi: 10.3390/pharmaceutics13101568.